ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 187 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,013,321 | +8.4% | 17,453 | +0.5% | 0.00% | +100.0% |
Q2 2023 | $934,866 | +44.9% | 17,367 | +6.9% | 0.00% | 0.0% |
Q1 2023 | $645,013 | -2.5% | 16,239 | -1.2% | 0.00% | 0.0% |
Q4 2022 | $661,421 | +27.9% | 16,441 | +2.1% | 0.00% | 0.0% |
Q3 2022 | $517,000 | +8.6% | 16,098 | +0.3% | 0.00% | 0.0% |
Q2 2022 | $476,000 | +18.4% | 16,055 | +12.2% | 0.00% | 0.0% |
Q1 2022 | $402,000 | -44.0% | 14,305 | -8.2% | 0.00% | 0.0% |
Q4 2021 | $718,000 | +62.1% | 15,586 | +15.5% | 0.00% | 0.0% |
Q3 2021 | $443,000 | -6.3% | 13,489 | -0.0% | 0.00% | 0.0% |
Q2 2021 | $473,000 | -7.1% | 13,494 | -4.1% | 0.00% | 0.0% |
Q1 2021 | $509,000 | +24.4% | 14,072 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $409,000 | +3.0% | 14,072 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $397,000 | -11.0% | 14,072 | +1.9% | 0.00% | 0.0% |
Q2 2020 | $446,000 | -20.6% | 13,805 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $562,000 | -36.0% | 13,805 | -3.1% | 0.00% | 0.0% |
Q4 2019 | $878,000 | -15.4% | 14,242 | 0.0% | 0.00% | -50.0% |
Q3 2019 | $1,038,000 | -10.3% | 14,242 | +1.2% | 0.00% | 0.0% |
Q2 2019 | $1,157,000 | +34.1% | 14,072 | +15.1% | 0.00% | 0.0% |
Q1 2019 | $863,000 | +53.3% | 12,231 | -2.2% | 0.00% | +100.0% |
Q4 2018 | $563,000 | -18.5% | 12,503 | +2.3% | 0.00% | 0.0% |
Q3 2018 | $691,000 | -15.3% | 12,224 | +0.0% | 0.00% | -50.0% |
Q2 2018 | $816,000 | +14.8% | 12,219 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $711,000 | -12.8% | 12,219 | -3.4% | 0.00% | 0.0% |
Q4 2017 | $815,000 | +19.7% | 12,647 | -2.6% | 0.00% | 0.0% |
Q3 2017 | $681,000 | +2.4% | 12,981 | -8.7% | 0.00% | +100.0% |
Q2 2017 | $665,000 | -14.0% | 14,212 | -9.0% | 0.00% | -50.0% |
Q1 2017 | $773,000 | -21.8% | 15,612 | -4.3% | 0.00% | 0.0% |
Q4 2016 | $989,000 | -11.3% | 16,312 | -3.0% | 0.00% | 0.0% |
Q3 2016 | $1,115,000 | +20.3% | 16,812 | +1.2% | 0.00% | 0.0% |
Q2 2016 | $927,000 | +64.9% | 16,612 | -0.5% | 0.00% | +100.0% |
Q1 2016 | $562,000 | -15.0% | 16,698 | +14.0% | 0.00% | -50.0% |
Q4 2015 | $661,000 | +16.2% | 14,644 | +1.8% | 0.00% | +100.0% |
Q3 2015 | $569,000 | -36.3% | 14,392 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $893,000 | +13.9% | 14,392 | +14.9% | 0.00% | 0.0% |
Q1 2015 | $784,000 | +9.2% | 12,526 | -1.6% | 0.00% | 0.0% |
Q4 2014 | $718,000 | +100.6% | 12,726 | +0.4% | 0.00% | +100.0% |
Q3 2014 | $358,000 | -17.5% | 12,672 | +0.6% | 0.00% | 0.0% |
Q2 2014 | $434,000 | – | 12,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |